Jasper Therapeutics, Inc. (JSPR)
0.51
+0.01
(+2.91%)
USD |
NASDAQ |
Oct 23, 16:00
0.52
+0.01
(+1.96%)
After-Hours: 20:00
Jasper Therapeutics Price to Book Value : 10.13 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 10.13 |
| October 22, 2026 | 9.849 |
| October 21, 2026 | 10.02 |
| October 20, 2026 | 9.934 |
| October 19, 2026 | 9.487 |
| October 16, 2026 | 9.537 |
| October 15, 2026 | 10.57 |
| October 14, 2026 | 9.956 |
| October 13, 2026 | 9.849 |
| October 12, 2026 | 11.03 |
| October 09, 2026 | 11.33 |
| October 08, 2026 | 11.13 |
| October 07, 2026 | 11.32 |
| October 06, 2026 | 11.13 |
| October 05, 2026 | 11.78 |
| October 02, 2026 | 11.23 |
| October 01, 2026 | 11.88 |
| September 30, 2026 | 11.53 |
| September 29, 2026 | 12.43 |
| September 28, 2026 | 12.44 |
| September 25, 2026 | 12.10 |
| September 24, 2026 | 11.63 |
| September 23, 2026 | 11.26 |
| September 22, 2026 | 12.38 |
| September 21, 2026 | 11.98 |
| Date | Value |
|---|---|
| September 18, 2026 | 12.28 |
| September 17, 2026 | 12.60 |
| September 16, 2026 | 11.54 |
| September 15, 2026 | 11.33 |
| September 14, 2026 | 12.58 |
| September 11, 2026 | 13.12 |
| September 10, 2026 | 13.92 |
| September 09, 2026 | 13.93 |
| September 08, 2026 | 14.10 |
| September 04, 2026 | 14.08 |
| September 03, 2026 | 13.64 |
| September 02, 2026 | 14.01 |
| September 01, 2026 | 13.86 |
| August 31, 2026 | 14.14 |
| August 28, 2026 | 13.90 |
| August 27, 2026 | 13.89 |
| August 26, 2026 | 14.27 |
| August 25, 2026 | 14.31 |
| August 24, 2026 | 14.36 |
| August 21, 2026 | 14.23 |
| August 20, 2026 | 13.74 |
| August 19, 2026 | 14.84 |
| August 18, 2026 | 14.90 |
| August 17, 2026 | 16.74 |
| August 14, 2026 | 15.70 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.32 |
| Anika Therapeutics, Inc. | 2.088 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.376 |
Price to Book Value Related Metrics
| Price | 0.51 |
| Earnings Yield | -310.0% |
| Market Cap | 14.32M |